Acutaas Chemicals, a company in the Pharmaceuticals industry, reported revenue of ₹437 crore and net profit of ₹123 crore for the September 2026 quarter.
Acutaas Chemicals (NSE: ACUTAAS) closed at ₹3,833.50 on 20 Nov 2026, up 121.3% over the past year. Its market capitalisation is ₹31,385 crore and it trades at 71.5 times earnings.
Ami Organics Limited is one of the leading research and development-driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, and materials for agrochemicals and fine chemicals.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.